Thailand Patient-derived Xenograft Model Market (2025-2031) | Size & Revenue, Analysis, Segmentation, Growth, Competitive Landscape, Companies, Industry, Forecast, Outlook, Value, Trends, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Patient-derived Xenograft Model Market Revenues & Volume, 2021 & 2031F

3.3 Thailand Patient-derived Xenograft Model Market - Industry Life Cycle

3.4 Thailand Patient-derived Xenograft Model Market - Porter's Five Forces

3.5 Thailand Patient-derived Xenograft Model Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F

3.6 Thailand Patient-derived Xenograft Model Market Revenues & Volume Share, By Model Type, 2021 & 2031F

3.7 Thailand Patient-derived Xenograft Model Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Growing focus on precision medicine and patient-specific treatment approaches

4.2.3 Rising prevalence of cancer and other diseases necessitating advanced research models

4.3 Market Restraints

4.3.1 High costs associated with developing and maintaining patient-derived xenograft models

4.3.2 Limited availability of skilled professionals for model development and experimentation

4.3.3 Ethical concerns related to the use of animal models in research

6.1 Thailand Patient-derived Xenograft Model Market, By Tumor Type

6.1.1 Overview and Analysis

6.1.2 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Tumor Type, 2021- 2031F

6.1.3 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.1.4 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.1.5 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.1.6 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.7 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Other Cancer, 2021- 2031F

6.2 Thailand Patient-derived Xenograft Model Market, By Model Type

6.2.1 Overview and Analysis

6.2.2 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Mice, 2021- 2031F

6.2.3 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Rats, 2021- 2031F

6.3 Thailand Patient-derived Xenograft Model Market, By End-user

6.3.1 Overview and Analysis

6.3.2 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F

6.3.3 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F

6.3.4 Thailand Patient-derived Xenograft Model Market Revenues & Volume, By CROs & CDMOs, 2021- 2031F

7.1 Thailand Patient-derived Xenograft Model Market Export to Major Countries

7.2 Thailand Patient-derived Xenograft Model Market Imports from Major Countries

8.1 Number of collaborations between research institutions and biopharmaceutical companies for PDX model development

8.2 Percentage increase in research publications utilizing PDX models in Thailand

8.3 Number of patents filed for innovations related to PDX model technologies in the country

9.1 Thailand Patient-derived Xenograft Model Market Opportunity Assessment, By Tumor Type, 2021 & 2031F

9.2 Thailand Patient-derived Xenograft Model Market Opportunity Assessment, By Model Type, 2021 & 2031F

9.3 Thailand Patient-derived Xenograft Model Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 Thailand Patient-derived Xenograft Model Market Revenue Share, By Companies, 2024

10.2 Thailand Patient-derived Xenograft Model Market Competitive Benchmarking, By Operating and Technical Parameters